Cited 11 times in
Delayed onset Mycobacterium intracellulare keratitis after laser in situ keratomileusis: A case report and literature review
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 고재상 | - |
dc.contributor.author | 김응권 | - |
dc.contributor.author | 김태임 | - |
dc.contributor.author | 용동은 | - |
dc.date.accessioned | 2018-07-20T11:59:42Z | - |
dc.date.available | 2018-07-20T11:59:42Z | - |
dc.date.issued | 2017 | - |
dc.identifier.issn | 0025-7974 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/161605 | - |
dc.description.abstract | RATIONALE: Infectious keratitis is a relatively uncommon but potentially sight-threatening complication of laser in situ keratomileusis (LASIK). Mycobacterial keratitis is usually regarded as late onset keratitis among post-LASIK keratitis. There has been no documented case of Mycobacterium intracellulare post-LASIK keratitis of a long-latent period. PATIENT CONCERNS: A 36-year-old man was referred to our out-patient clinic, for persistent corneal epithelial defect with intrastromal infiltration. He had undergone uneventful bilateral LASIK procedure 4 years before. He complained decreased vision, accompanied by ocular pain, photophobia, and redness in his left eye for 7 months. DIAGNOSIS: Lamellar keratectomy was taken using femtosecond laser. Bacterial culture with sequenced bacterial 16s ribosomal DNA confirmed the organism to be M intracellulare. INTERVENTIONS: After 3 months of administration of topical clarithromycin, amikacin, and moxifloxacin, the corneal epithelial defect was resolved and the infiltration was much improved. However, newly developed diffuse haziness with surrounding granular infiltration in the central cornea was noted. Drug toxicity was suspected and topical moxifloxacin was discontinued, resulting in resolution of the diffuse haze with infiltration. OUTCOME: The patient was followed up regularly without medication thereafter and recurrence was not found for 7 years. LESSONS: This case presents the first case of M intracellulare keratitis after LASIK. LASIK surgeons should aware that post-LASIK keratitis can develop long after the operation and careful suspicion of infectious disease with meticulous diagnostic test is needed. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Lippincott Williams & Wilkins | - |
dc.relation.isPartOf | MEDICINE | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Administration, Topical | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Amikacin/therapeutic use | - |
dc.subject.MESH | Anti-Bacterial Agents/therapeutic use | - |
dc.subject.MESH | Clarithromycin/therapeutic use | - |
dc.subject.MESH | Drug Therapy, Combination | - |
dc.subject.MESH | Eye Infections, Bacterial/diagnosis | - |
dc.subject.MESH | Eye Infections, Bacterial/drug therapy | - |
dc.subject.MESH | Eye Infections, Bacterial/etiology | - |
dc.subject.MESH | Fluoroquinolones/therapeutic use | - |
dc.subject.MESH | Follow-Up Studies | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Keratitis/drug therapy | - |
dc.subject.MESH | Keratitis/etiology | - |
dc.subject.MESH | Keratitis/microbiology | - |
dc.subject.MESH | Keratomileusis, Laser In Situ/adverse effects | - |
dc.subject.MESH | Keratomileusis, Laser In Situ/methods | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Mycobacterium avium Complex/isolation & purification | - |
dc.subject.MESH | Severity of Illness Index | - |
dc.subject.MESH | Treatment Outcome | - |
dc.title | Delayed onset Mycobacterium intracellulare keratitis after laser in situ keratomileusis: A case report and literature review | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine | - |
dc.contributor.department | Dept. of Ophthalmology | - |
dc.contributor.googleauthor | JaeSang Ko | - |
dc.contributor.googleauthor | Se Kyung Kim | - |
dc.contributor.googleauthor | Dong Eun Yong | - |
dc.contributor.googleauthor | Tae-im Kim | - |
dc.contributor.googleauthor | Eung Kweon Kim | - |
dc.identifier.doi | 10.1097/MD.0000000000009356 | - |
dc.contributor.localId | A04876 | - |
dc.contributor.localId | A00831 | - |
dc.contributor.localId | A01080 | - |
dc.contributor.localId | A02423 | - |
dc.relation.journalcode | J02214 | - |
dc.identifier.eissn | 1536-5964 | - |
dc.identifier.pmid | 29390522 | - |
dc.contributor.alternativeName | Ko, Jaesang | - |
dc.contributor.alternativeName | Kim, Eung Kweon | - |
dc.contributor.alternativeName | Kim, Tae Im | - |
dc.contributor.alternativeName | Yong, Dong Eun | - |
dc.contributor.affiliatedAuthor | Ko, Jaesang | - |
dc.contributor.affiliatedAuthor | Kim, Eung Kweon | - |
dc.contributor.affiliatedAuthor | Kim, Tae Im | - |
dc.contributor.affiliatedAuthor | Yong, Dong Eun | - |
dc.citation.volume | 96 | - |
dc.citation.number | 51 | - |
dc.citation.startPage | e9356 | - |
dc.identifier.bibliographicCitation | MEDICINE, Vol.96(51) : e9356, 2017 | - |
dc.identifier.rimsid | 61629 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.